ZENPEP (Aptalis Pharma US, Inc.)
Welcome to the PulseAid listing for the ZENPEP drug offered from Aptalis Pharma US, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aptalis Pharma US, Inc. |
NON-PROPRIETARY NAME: | pancrelipase |
SUBSTANCE NAME: | PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-09-22 |
END MARKETING DATE: | 0000-00-00 |
ZENPEP HUMAN PRESCRIPTION DRUG Details:
Item Description | ZENPEP from Aptalis Pharma US, Inc. |
LABELER NAME: | Aptalis Pharma US, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5000; 17000; 27000([USP’U]/1; [USP’U]/1; [USP’U]/1) |
START MARKETING DATE: | 2009-09-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42865-300_e2fd582b-c0ba-4474-b309-62d8ef066c40 |
PRODUCT NDC: | 42865-300 |
APPLICATION NUMBER: | NDA022210 |
Other PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE Pharmaceutical Manufacturers / Labelers: